Skip to main content
Equibles
BNTC logo

BNTC · Benitec Biopharma Inc. · Metrics

Track BNTC — free

Use BNTC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BNTC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.54 +0.90 (+10.42%) At close · Nov 6
Russell 2000 member Rebalance outlook locked
Market Cap
$332.78M
Shares
34.88M
Volume · Nov 6 120.37K Avg daily vol (3M) 186.02K

BNTC metrics

68 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.54
Market cap
$332.78M

Price action

23 metrics
Price change (1W)
-2.2%
Price change (30D)
-3.9%
Price change (3M)
-34.2%
Price change (6M)
-28.8%
Price change (YTD)
-35.9%
Price change (1Y)
-45.2%
Trailing year
Price change (5Y)
—
52-week high
$15.78
52-week low
$8.11
Change from 52-week high
-45.2%
Change from 52-week low
+6.5%
Annualized volatility
61.7%
Annualized volatility (3M)
60.3%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.6
RSI (14D)
44.4
Price vs SMA 50
-14.0%
Price vs SMA 200
-24.7%
Avg volume (3M)
185,444
Relative volume
1.7
Average dollar volume
$1.96M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
34.88M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.7
reciprocal yield 58.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-15.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
994.1×
reciprocal yield 0.1%
EV / revenue historical average (5Y)
878.8×
reciprocal yield 0.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-14

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$51.19M
Net income (TTM)
−$45.55M
Trailing 12 months
Diluted EPS (TTM)
$-0.98
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.09
EBITDA per diluted share (TTM)
$-1.09
Net income per diluted share (TTM)
$-0.97
Operating cash flow per diluted share (TTM)
$-0.35
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.50
Stock compensation per diluted share (TTM)
$0.57
Book value per share
$5.14

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+27.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-25.7%
Return on assets
-24.9%
Debt / equity
0.0
Current ratio
34.0
EBITDA (TTM)
−$51.13M
Free cash flow (TTM)
—
Quick ratio
34.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$179.97M
Latest balance sheet
Cash & equivalents
$179.97M
Total assets
$182.62M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$16.52M
Capital expenditures (TTM)
—
R&D (TTM)
$23.39M
SG&A (TTM)
—
Stock compensation (TTM)
$26.41M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
86
13F filer change QoQ
-2
Institutional ownership
95.0%
Conviction holders (share of 13F filers)
2.3%
Crowding (high-turnover and private-fund holders)
67.4%
Private-fund adviser ownership
67.3%
Active holders' share change QoQ
+1.1%
Holder tenure
12.2
Price vs estimated holder cost
+7.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.5%

Short interest

3 metrics
Short interest
5.7%
Latest settlement · 10.1 days to cover
Days to cover
10.1d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1808898 CUSIP 08205P209 13F (30d) 24 filings 24 filers Visit website Investor relations